Last reviewed · How we verify
NCT03773419: T-WRITE
Improving Electronic Written Communication in Aphasia
NA trial testing Texting Intervention (T-WRITE) in Aphasia in 63 participants. Completed in 30 September 2022.
13 August 2021
Quick facts
| Lead sponsor | Shirley Ryan AbilityLab |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 63 |
| Start date | 20 September 2018 |
| Primary completion | 13 August 2021 |
| Estimated completion | 30 September 2022 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Texting Intervention (T-WRITE)
- HandWriting Intervention (ORLA+WTG)
Conditions studied
- Aphasia — all drugs for Aphasia →
Sponsor
Shirley Ryan AbilityLab — full company profile →
Who can join
18 and older, any sex, with Aphasia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
People with aphasia have difficulty with writing and often struggle to use electronic communication that connects people to one another. The goal of this project is to evaluate the extent to which a novel treatment (T-WRITE) improves written language function and the use of text messaging; we also evaluate whether there are subsequent positive effects on the participant's social connectedness and ultimately health-related quality of life (HRQOL). T-WRITE involves choral reading and repeated writing of sentences via texting. Participants work intensively and independently at home on a laptop computer. A virtual therapist directs the participant to practice copying and independently writing phrases and short sentences using the typing feature on a cellular phone. The specific objective of this randomized clinical trial is to compare T-WRITE to ORLA+WTG, a similar treatment that targets written expression using handwriting.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Texting Behaviors of Individuals With Chronic Aphasia: A Descriptive Study.
Kinsey LE, Lee JB, Larkin EM, Cherney LR. · · 2022 · cited 9× · PMID 34061572 · DOI 10.1044/2021_ajslp-20-00287 -
Transactional Success in the Texting of Individuals With Aphasia.
Lee JB, Cherney LR. · · 2022 · cited 6× · PMID 35623321 · DOI 10.1044/2022_ajslp-21-00291 -
Validity and Reliability of the Transactional EXchanges in Texting for Aphasia Rating Scale.
Lee JB, Azios JH, Fergadiotis G, McMahon MF, et al · · 2025 · cited 1× · PMID 41159821 · DOI 10.1044/2025_jslhr-25-00086
Verify or expand the search:
- PubMed search for NCT03773419
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aphasia
Currently open trials in the same condition.
- NCT07460037 — Chinese-Specific Speech Imagery Coding Using High-Density ECoG · NA · recruiting
- NCT07397923 — Exploratory Evaluation of the Digital Therapeutic Device Zenicom for Subacute Stroke Aphasia · Phase 2 · recruiting
- NCT07281313 — Aphasia Physical EXercise Study: Randomized Trial · NA · recruiting
- NCT06990997 — Effects of Aphasia Identification Cards on Service Workers' Comprehension of People With Aphasia · NA · recruiting
- NCT06974279 — Post-Stroke Aphasia TMS · NA · recruiting
Other Shirley Ryan AbilityLab trials
Trials by the same sponsor.
- NCT07434492 — Smart AFO and 5-Azacitidine to Enhance Mobility in Children With Cerebral Palsy · Phase 2 · not yet recruiting
- NCT07433023 — tSCS and 5-Azacitidine for Enhanced Motor Outcomes in Cerebral Palsy · Phase 2 · not yet recruiting
- NCT06999213 — Lower Limb ExoNET: Development and Evaluation for Gait Assistance With Stroke Survivors · EARLY_PHASE1 · not yet recruiting
- NCT07032753 — Neuromusculoskeletal Interface for Bionic Arms · NA · not yet recruiting
- NCT07223710 — Improving Walking After Spinal Cord Injury · Phase 1, PHASE2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03773419 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shirley Ryan AbilityLab
- Last refreshed: 26 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03773419.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing